Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway

International Journal of Clinical Oncology

Volumn 20, Issue 3, 2015, Pages 508-517

  Luo, Qingquan ^a   Lin, Hao ^b   Ye, Xiangyun ^b   Huang, Jia ^b   Lu, Shun ^b   Xu, Lin ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c JIANGSU CANCER HOSPITAL   (China)

Author keywords

Invasion; Migration; NF B; NSCLC; Trim44

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA; TRIPARTITE MOTIF CONTAINING 4 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHEMOKINE RECEPTOR; CXCR6 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; TRIM44 PROTEIN, HUMAN; VIRUS RECEPTOR;

16HE CELL LINE; A549 CELL LINE; ARTICLE; BRONCHUS MUCOSA; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; METASTASIS POTENTIAL; MOLECULAR PATHOLOGY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; BIOSYNTHESIS; CELL MOTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY;

CARRIER PROTEINS; CELL MOVEMENT; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION;

EID: 84930573457     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0752-9     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics CA. Cancer J Clin 61:69–90
2. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
3. Carthagena L, Bergamaschi A, Luna JM et al (2009) Human TRIM gene expression in response to interferons. PLoS One 4:e4894
4. McNab FW, Rajsbaum R, Stoye JP et al (2011) Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 23:46–56
5. Ozato K, Shin DM, Chang TH et al (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8:849–860
6. Jefferies C, Wynne C, Higgs R (2011) Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 11:617–625
7. Li Q, Yan J, Mao AP et al (2011) Tripartite motif 8 (TRIM8) modulates TNFalpha- and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci USA 108:19341–19346
8. Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799–808
9. Bieniasz PD (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5:1109–1115
10. Yang K, Shi HX, Liu XY et al (2009) TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 182:3782–3792
11. Boutou E, Matsas R, Mamalaki A (2001) Isolation of a mouse brain cDNA expressed in developing neuroblasts and mature neurons. Brain Res Mol Brain Res 86:153–167
12. Yang B, Wang J, Wang Y (2013) Novel function of Trim44 promotes an antiviral response by stabilizing VISA. J Immunol 190:3613–3619
13. Peters CJ, Rees JR, Hardwick RH et al (2010) A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139(e1915):1995–2004
14. Jarvinen AK, Autio R, Kilpinen S et al (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosom Cancer 47:500–509
15. Kashimoto K, Komatsu S, Ichikawa D et al (2012) Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Sci 103:2021–2026
16. Hu Y, Wang J, Yang B (2011) Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J Immunol 187:6456–6462
17. Beck G, Yard BA, Schulte J et al (2003) Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium. Biochem Biophys Res Commun 300:731–737
18. Chen L, Chen DT, Kurtyka C et al (2012) Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287:40106–40118
19. Zhou ZY, Yang GY, Zhou J et al (2012) Significance of TRIM29 and beta-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 75:269–274
20. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327–336
21. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science (New York) 285:1028–1032
22. Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9:289–303
23. Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749–755
24. Papathoma AS, Zoumpourlis V, Balmain A et al (2001) Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis. Mol Carcinog 31:74–82
25. Cockett MI, Murphy G, Birch ML et al (1998) Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp 63:295–313
26. Bianco FJ Jr, Gervasi DC, Tiguert R et al (1998) Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res 4:3011–3016
27. Lee JM, Dedhar S, Kalluri R et al (2006) The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973–981
28. Tsuruta D (2009) NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 3:40–48
29. Wang S, Uchi H, Hayashida S et al (2009) Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-kappaB p105/p50 in chronic inflammatory skin diseases. J Dermatol 36:534–540